Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced that members of the management team ...
Full year 2025 business update and financial results conference call to be held March 12 at 4:30 p.m. ETStockholder fireside chat to be held on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results